EconPapers    
Economics at your fingertips  
 

Antimicrobial Peptide Brevinin-2isb, New Drug Candidates Enhance the Innate Immune Response and Cured Caenorhabditis Elegans With Methicillin-Resistant Staphylococcus Aureus (MRSA)

Hui Xie, Xueli Chen, Qi Zeng, Yonghua Zhan, Xinyi Xu, Dan Chen and Jimin Liang
Additional contact information
Jimin Liang: School of Life Science and Technology, China

Biomedical Journal of Scientific & Technical Research, 2019, vol. 13, issue 4, 1-2

Abstract: Antimicrobial peptide is supposed to solve the problem of drug resistance by pathogenic bacteria. Brevinin-2ISb is rich in amphibian skin and has been reported to have a wide range antimicrobial activity especially for MRSA bacteria (G+)...

Keywords: Biomedical Sciences, Biomedical Research, Technical Research, Brevinin-2ISb; Innate Immune Response; Caenorhabditis elegans; MRSA (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.002446.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.002446.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:13:y:2019:i:4:p:1-2

DOI: 10.26717/BJSTR.2019.13.002446

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().

 
Page updated 2025-03-19
Handle: RePEc:abf:journl:v:13:y:2019:i:4:p:1-2